David M. Goldenberg
2013
In 2013, David M. Goldenberg earned a total compensation of $1.6M as Chairman, Chief Scientific Officer and Chief Patent Officer at Immunomedics.
Compensation breakdown
| Non-Equity Incentive Plan | $282,365 |
|---|---|
| Option Awards | $317,986 |
| Salary | $564,730 |
| Stock Awards | $296,522 |
| Other | $153,125 |
| Total | $1,614,728 |
Goldenberg received $564.7K in salary, accounting for 35% of the total pay in 2013.
Goldenberg also received $282.4K in non-equity incentive plan, $318K in option awards, $296.5K in stock awards and $153.1K in other compensation.
Rankings
In 2013, David M. Goldenberg's compensation ranked 4,650th out of 12,286 executives tracked by ExecPay. In other words, Goldenberg earned more than 62.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,650 out of 12,286 | 62nd |
Division Manufacturing | 1,595 out of 4,612 | 65th |
Major group Chemicals And Allied Products | 465 out of 1,466 | 68th |
Industry group Drugs | 326 out of 1,160 | 72nd |
Industry In Vitro and In Vivo Diagnostic Substances | 15 out of 56 | 73rd |
Source: SEC filing on October 21, 2015.
Goldenberg's colleagues
We found one more compensation record of an executive who worked with David M. Goldenberg at Immunomedics in 2013.
2013
Cynthia Sullivan
Immunomedics